Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol for Hemorrhage Prevention in Elective Caesarean Delivery
NCT01931410Phase 4Completed
- Start
- Jun 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of misoprostol in postpartum hemorrhage (PPH) and intrapartum hemorrhage. Primary endpoint: Postpartum Haemorrhage at 24 hours. Started Jun 2013; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)intrapartum hemorrhage
Beyond the preview
Go deeper on NCT01931410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01931410.